The BPC-157 capsule format offers a convenient and non-invasive method for systemic support
[] Setmelanotide has demonstrated efficacy in reducing weight for BBS patients, and is currently being evaluated in clinical trials for hyperphagia-related weight gain in ALMS patients
This has been shown to increase glutathione levels in the body
This form is the most stable for shipping and long-term storage the peptide stays intact in a dry, inert state far longer than it would in solution
Subsequent work demonstrated improved cardiac function, enhanced neuronal survival under stress, and a 5% extension of healthy lifespan in mouse models
Gastrointestinal protection: BPC-157 was originally discovered in gastric juice and has been shown to protect the gastrointestinal tract from damage caused by various agents, such as NSAIDs (nonsteroidal anti-inflammatory drugs), alcohol, and stress